1. Presented at the Bank of Americas Securities Healthcare Institutional Conference, July 7, 2004.
2. U.S. Department of Health and Human Services, Food and Drug Administration. Innovation/Stagnation. Challenge and Opportunity on the Critical Path to New Medical Products, March 2004.
3. Food and Drug Administration Searle Investigation Task Force. Report of Preclinical (Animal) Studies of G.D. Searle Company Skokie Illinois, March 1976.
4. Principles in quality assurance. Part 2. Don't hide behind the regulations